A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Каталог · ЕАЭС
Клинические исследования и проекты
Human Genome Sciences Inc., a GSK Company · найдено 3
3 исследования
Завершено
Фаза III
Россия
Placebo; Belimumab 10 mg/kg; Azathioprine · Human Genome Sciences Inc., a GSK Company
Завершено
Фаза III
Россия
belimumab · Human Genome Sciences Inc., a GSK Company
A Multi-Center, Continuation Trial of Belimumab (HGS1006, LymphoStat-B™)a Fully Human Monoclonal Anti-BLyS Antibody in Subjects With Systemic Lupus Erythematosus (SLE) Who Completed the Phase 3 Protocol HGS1006-C1056 or HGS1006-C1057
Завершено
Фаза III
Россия
Placebo plus standard therapy; Belimumab 10 mg/kg plus standard therapy; Standard therapy · Human Genome Sciences Inc., a GSK Company
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis